Anterior cervical discectomy and fusion (ACDF) is the most commonly used decompressive procedure in the cervical spine and is used for the treatment of single or multiple level disc disease.

H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on FibroBiologics, Inc. (FBLG – Research Report) today and set a price ...

Theradaptive, a privately held, clinical stage biologics company developing targeted protein therapeutics for spine, orthopedics, soft tissue repair and targeted immuno-oncology, today announced the ...

Degenerative Disc Disease (DDD) Procedure: Bone Marrow Concentrate that ... “Physical therapy plays a crucial role in the non-surgical management of spine problems. after the treatment Trained ...

The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to a standalone lateral lumbar interbody fusion device from the internationally renowned surgeon Randal Betz, M.D.’s company, ...

NASS’s 2024 Research Funding Program announced grants and traveling fellowships winners totaling $159,059 this year.

Research shows that 90% of individuals will experience some form of back pain in their lives, and among these, many could prevent chronic pain through preventive spine care. Clinically, spine health ...

Lower back surgery represents a life-changing decision that demands careful consideration. While many view surgery as a ...

BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) announced the company’s 3Q 2024 financial results and while a company at this stage is far more reliant on testing of products, ...

The treatment is intended for patients whose pain has not ... We have commenced a Phase 2 clinical trial using BRTX-100 to ...

Conditions treated at the spine center include neck pain and stiffness, lower back pain, sciatica, scoliosis, pinched nerves, spinal stenosis, degenerative disc disease ... patients can receive ...